 | Up a level |
Journal Article
Agostinetto, Elisa 
ORCID: 0000-0003-0295-7511, Ameye, Lieveke, Martel, Samuel, Aftimos, Philippe, Ponde, Noam, Maurer, Christian ORCID: 0000-0003-4388-5163, El-Abed, Sarra, Wang, Yingbo, Vicente, Malou, Chumsri, Saranya, Bliss, Judith ORCID: 0000-0001-7957-7424, Kroep, Judith, Colleoni, Marco, Petrelli, Fausto, Del Mastro, Lucia, Moreno-Aspitia, Alvaro, Piccart, Martine, Paesmans, Marianne, de Azambuja, Evandro and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2022).
PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer.
npj Breast Cancer, 8 (1).
BERLIN:
NATURE PORTFOLIO.
ISSN 2374-4677
Brandao, Mariana ORCID: 0000-0002-1653-3544, Maurer, Christian, Ziegelmann, Patricia Klarmann, Ponde, Noam F., Ferreira, Arlindo ORCID: 0000-0002-1567-9322, Martel, Samuel, Piccart, Martine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509, Debiasi, Marcio and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2020).
Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis.
ESMO Open, 5 (4).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Ferreira, Arlindo R., Ferreira, Sofia, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Maurer, Christian, Martel, Samuel, Costa, Luis, Ponde, Noam and de Azambuja, Evandro ORCID: 0000-0001-9501-4509
(2021).
Association between pertuzumab-associated diarrhoea and rash and survival outcomes in patients with HER2-positive metastatic breast cancer: Exploratory analysis from the CLEOPATRA trial.
Eur. J. Cancer, 144.
S. 351 - 360.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1879-0852
Martel, Samuel, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Maurer, Christian, Ponde, Noam Falbel, Ferreira, Arlindo R., Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, Prady, Catherine, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2018).
Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.
Cancer Treat. Rev., 62.
S. 123 - 133.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1532-1967
Martel, Samuel, Lambertini, Matteo, Agbor-Tarh, Dominique, Ponde, Noam F., Gombos, Andrea, Paterson, Vicki, Hilbers, Florentine ORCID: 0000-0002-6764-3102, Korde, Larissa, Manukyants, Anna, Dueck, Amylou, Maurer, Christian, Piccart, Martine, Moreno-Aspitia, Alvaro, Desmedt, Christine ORCID: 0000-0002-5223-5579, Di Cosimo, Serena and de Azambuja, Evandro
(2021).
Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial.
J. Natl. Compr. Cancer Netw., 19 (2).
S. 181 - 203.
HUNTINGTON:
HARBORSIDE PRESS.
ISSN 1540-1413
Maurer, Christian, Ferreira, Arlindo R., Martel, Samuel, Lambertini, Matteo ORCID: 0000-0003-1797-5296, Ponde, Noam, Aftimos, Philippe, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Piccart, Martine
(2018).
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.
Breast, 39.
S. 14 - 19.
EDINBURGH:
CHURCHILL LIVINGSTONE.
ISSN 1532-3080
Maurer, Christian, Martel, Samuel and de Azambuja, Evandro ORCID: 0000-0001-9501-4509
(2017).
Male breast cancer: finding the way in this uncommon path.
ESMO Open, 2 (1).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Maurer, Christian, Tulpin, Lorraine, Moreau, Michel, Dumitrescu, Cristina, de Azambuja, Evandro ORCID: 0000-0001-9501-4509, Paesmans, Marianne, Nogaret, Jean-Marie, Piccart, Martine J. and Awada, Ahmad
(2018).
Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.
ESMO Open, 3 (6).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Poggio, Francesca ORCID: 0000-0002-4518-2827, Bruzzone, Marco ORCID: 0000-0002-8821-4542, Ceppi, Marcello ORCID: 0000-0002-8177-8003, Conte, Benedetta, Martel, Samuel, Maurer, Christian, Tagliamento, Marco ORCID: 0000-0001-7461-023X, Viglietti, Giulia, Del Mastro, Lucia ORCID: 0000-0002-9546-5841, de Azambuja, Evandro ORCID: 0000-0001-9501-4509 and Lambertini, Matteo ORCID: 0000-0003-1797-5296
(2018).
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.
ESMO Open, 3 (4).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2059-7029
Tutt, Andrew N. J., Garber, Judy E., Kaufman, Bella, Viale, Giuseppe, Fumagalli, Debora, Rastogi, Priya, Gelber, Richard D., de Azambuja, Evandro ORCID: 0000-0001-9501-4509, Fielding, Anitra, Balmana, Judith, Domchek, Susan M., Gelmon, Karen A., Hollingsworth, Simon J., Korde, Larissa A., Linderholm, Barbro, Bandos, Hanna, Senkus, E., Suga, Jennifer M., Shao, Z., Pippas, Andrew W., Nowecki, Zbigniew, Huzarski, Tomasz, Ganz, Patricia A., Lucas, Peter C., Baker, Nigel, Loibl, Sibylle, McConnell, Robin, Piccart, Martine, Schmutzler, Rita, Steger, Guenther G., Costantino, Joseph P., Arahmani, Amal, Wolmark, Norman, McFadden, Eleanor, Karantza, Vassiliki, Lakhani, Sunil R., Yothers, Greg ORCID: 0000-0002-7965-7333, Campbell, Christine and Geyer, Charles E.
(2021).
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N. Engl. J. Med., 384 (25).
S. 2394 - 2406.
WALTHAM:
MASSACHUSETTS MEDICAL SOC.
ISSN 1533-4406